4.7 Article

First case of postmortem study in a patient vaccinated against SARS-CoV-2

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel et al.

Summary: The two vaccine candidates, BNT162b1 and BNT162b2, developed contain modified messenger RNA encoding immunogens derived from the spike glycoprotein of SARS-CoV-2. They have shown promising immune responses in mice and rhesus macaques, with ongoing phase I trials in Germany and the USA and a global phase II/III trial for BNT162b2.

NATURE (2021)

News Item Medicine, General & Internal

Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Letter Gastroenterology & Hepatology

Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19

Barbara Kaltschmidt et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Letter Medicine, General & Internal

Postmortem Examination of Patients With COVID-19

Tina Schaller et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, Legal

Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany

Carolin Edler et al.

INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)

Article Multidisciplinary Sciences

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Neeltje van Doremalen et al.

NATURE (2020)